valine has been researched along with cyclic gmp in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (21.05) | 18.7374 |
| 1990's | 4 (21.05) | 18.2507 |
| 2000's | 7 (36.84) | 29.6817 |
| 2010's | 4 (21.05) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baron, BM; McDonald, IA; Miller, F; Muench, D; White, HS; Whitten, JP | 1 |
| Henneberry, RC; Novelli, A | 1 |
| Canning, HM; Leach, MJ; Marden, CM | 1 |
| Collins, JF; Foster, GA; Roberts, PJ; Sharif, NA | 1 |
| Nair, NP; Pilapil, C; Richard, JW; Wood, PL | 1 |
| Olias, G; Richter, D; Schmale, H | 1 |
| Hu, PS; Ross, SB | 1 |
| Bohlender, J; Dietz, R; Haass, M; Höhnel, K; Luft, FC; Scheuermann, M; Thibault, G; Willenbrock, R | 1 |
| Carey, RM; de Gasparo, M; El-Kersh, M; Siragy, HM | 1 |
| Carey, RM; De Gasparo, M; El-Kersh, MA; Siragy, HM; Webb, RL | 1 |
| Abadir, PM; Carey, RM; Siragy, HM | 1 |
| Isaka, N; Ito, M; Kaibuchi, K; Kongo, M; Kureishi, Y; Moriki, N; Nakakuki, T; Nakano, T; Okamoto, R; Seko, T | 1 |
| Barker, TA; Berk, BC; Kennedy, AJ; Korshunov, VA; Massett, MP; Mohan, AM | 1 |
| Brown, NJ; Gebretsadik, T; LeFebvre, J; Murphey, LJ; Petro, JR; Shintani, A | 1 |
| Black, KD; Flynn, GE; Islas, LD; Sankaran, B; Zagotta, WN | 1 |
| Burnett, AL; Ferreira, JM; Rameau, GA | 1 |
| Amakawa, T; Kan, H; Kataoka-Shirasugi, N | 1 |
| Bucci, M; Cirino, G; Coletta, C; Giannis, A; Papapetropoulos, A; Szabo, C; Topouzis, S; von Wantoch Rekowski, M; Zhou, Z | 1 |
| Akimoto, T; Fujita, D; Hirata, Y; Kiyosue, A; Komuro, I; Morishita, Y; Myojo, M; Nagai, R; Nagata, D; Satonaka, H; Takahashi, M | 1 |
1 trial(s) available for valine and cyclic gmp
| Article | Year |
|---|---|
Bradykinin B(2) receptor does not contribute to blood pressure lowering during AT(1) receptor blockade.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Blood Pressure; Bradykinin; Bradykinin B2 Receptor Antagonists; Cross-Over Studies; Cyclic GMP; Diet, Sodium-Restricted; Female; Heart Rate; Humans; Hypertension; Male; Receptor, Bradykinin B2; Renin; Sodium; Tetrazoles; Valine; Valsartan | 2007 |
18 other study(ies) available for valine and cyclic gmp
| Article | Year |
|---|---|
(R)-4-oxo-5-phosphononorvaline: a new competitive glutamate antagonist at the NMDA receptor complex.
Topics: Animals; Binding, Competitive; Cerebellum; Cyclic GMP; Excitatory Amino Acid Antagonists; Glutamates; Glutamic Acid; Kindling, Neurologic; Mice; Mice, Inbred DBA; N-Methylaspartate; Rats; Receptors, N-Methyl-D-Aspartate; Valine | 1990 |
Veratrine- and glutamate-stimulated cGMP production in cultured rat neurons is differentially inhibited by imipramine.
Topics: 2-Amino-5-phosphonovalerate; Animals; Cells, Cultured; Cerebellum; Cyclic GMP; Cytoplasmic Granules; Glutamates; Glutamic Acid; Imipramine; Neurons; Rats; Tetrodotoxin; Valine; Veratrine | 1985 |
(+/-)-cis-2,3-Piperidine dicarboxylic acid is a partial N-methyl-D-aspartate agonist in the in vitro rat cerebellar cGMP model.
Topics: 2-Amino-5-phosphonovalerate; Amino Acids; Animals; Anticonvulsants; Aspartic Acid; Cerebellum; Cyclic GMP; Dose-Response Relationship, Drug; Female; In Vitro Techniques; Magnesium; Male; N-Methylaspartate; Pipecolic Acids; Rats; Rats, Inbred Strains; Valine | 1986 |
Phosphonate analogues of acidic amino acids: inhibition of excitatory amino acid transmitter binding to cerebellar membranes and of the stimulation of cerebellar cyclic GMP levels.
Topics: 2-Amino-5-phosphonovalerate; Alanine; Amino Acids; Aminobutyrates; Animals; Cerebellum; Cyclic GMP; Rats; Receptors, Amino Acid; Receptors, Cell Surface; Receptors, Neurotransmitter; Stereoisomerism; Valine | 1982 |
Antagonists of excitatory amino acids and cyclic guanosine monophosphate in cerebellum.
Topics: 2-Amino-5-phosphonovalerate; Amino Acids; Animals; Behavior, Animal; Brain Chemistry; Cerebellum; Cyclic GMP; Male; Mice; Valine | 1982 |
Heterologous expression of human vasopressin-neurophysin precursors in a pituitary cell line: defective transport of a mutant protein from patients with familial diabetes insipidus.
Topics: Amino Acid Sequence; Animals; Arginine Vasopressin; Cell Line; Conserved Sequence; Cyclic GMP; Diabetes Insipidus; Fluorescent Antibody Technique; Glycine; Glycosylation; Humans; Mice; Netherlands; Neurophysins; Oxytocin; Pituitary Gland; Pituitary Neoplasms; Point Mutation; Protein Precursors; Recombinant Proteins; Transfection; Valine; Vasopressins | 1996 |
NMDA receptor-mediated increase in cyclic GMP in the rat cerebellum in vivo is blocked by alaproclate and GEA-857.
Topics: 4-Aminopyridine; Alanine; Animals; Behavior, Animal; Cerebellum; Convulsants; Cyclic GMP; Drug Interactions; Harmaline; Male; N-Methylaspartate; Pentylenetetrazole; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Seizures; Selective Serotonin Reuptake Inhibitors; Valine | 1997 |
Angiotensin inhibition and atrial natriuretic peptide release after acute volume expansion in rats with aortocaval shunt.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Blood Volume; Cyclic GMP; Diuresis; Heart Failure; Male; Myocardium; Ramipril; Rats; Rats, Wistar; Renin-Angiotensin System; Statistics, Nonparametric; Tetrazoles; Valine; Valsartan | 1999 |
Angiotensin-converting enzyme inhibition potentiates angiotensin II type 1 receptor effects on renal bradykinin and cGMP.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzazepines; Bradykinin; Cyclic GMP; Drug Synergism; Extracellular Space; Imidazoles; Kidney; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Sodium; Tetrazoles; Valine; Valsartan | 2001 |
Differences in AT2 -receptor stimulation between AT1 -receptor blockers valsartan and losartan quantified by renal interstitial fluid cGMP.
Topics: Administration, Oral; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Blood Pressure; Cyclic GMP; Extracellular Space; Female; Imidazoles; Injections, Intravenous; Kidney; Losartan; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Tetrazoles; Valine; Valsartan | 2002 |
Angiotensin AT2 receptors directly stimulate renal nitric oxide in bradykinin B2-receptor-null mice.
Topics: Angiotensin Receptor Antagonists; Animals; Blood Pressure; Cyclic GMP; Extracellular Space; Imidazoles; Kidney; Mice; Mice, Knockout; Nitrates; Nitric Oxide; Nitrites; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptor, Bradykinin B2; Receptors, Angiotensin; Receptors, Bradykinin; Sodium; Tetrazoles; Valine; Valsartan | 2003 |
RhoA activation in vascular smooth muscle cells from stroke-prone spontaneously hypertensive rats.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Aorta; Cells, Cultured; Cyclic AMP; Cyclic GMP; Hypertension; Muscle, Smooth, Vascular; Prazosin; Rats; Rats, Inbred SHR; Rats, Inbred WKY; rho GTP-Binding Proteins; rhoA GTP-Binding Protein; Signal Transduction; Stroke; Tetrazoles; Valine; Valsartan | 2004 |
Angiotensin II type 2 receptor expression after vascular injury: differing effects of angiotensin-converting enzyme inhibition and angiotensin receptor blockade.
Topics: Amlodipine; Angiotensin II Type 2 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzazepines; Blood Pressure; Carotid Artery, Common; Cyclic GMP; Male; Rats; Rats, Inbred BN; Receptor, Angiotensin, Type 2; Tetrazoles; Tunica Intima; Tunica Media; Valine; Valsartan | 2006 |
Structure and rearrangements in the carboxy-terminal region of SpIH channels.
Topics: Allosteric Regulation; Amino Acid Substitution; Animals; Carrier Proteins; Crystallography, X-Ray; Cyclic AMP; Cyclic GMP; Cyclic Nucleotide-Gated Cation Channels; DNA, Complementary; Dose-Response Relationship, Drug; Female; Hydrogen Bonding; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Ion Channel Gating; Ligands; Microinjections; Models, Biological; Models, Chemical; Models, Molecular; Oocytes; Patch-Clamp Techniques; Potassium Channels; Protein Structure, Secondary; Protein Structure, Tertiary; Protein Subunits; Recombinant Fusion Proteins; RNA, Messenger; Valine; Xenopus | 2007 |
Activity-dependent regulation of surface glucose transporter-3.
Topics: 4-Aminopyridine; Analysis of Variance; Animals; Bicuculline; Biotinylation; Cerebral Cortex; Cyclic GMP; Disks Large Homolog 4 Protein; Dogs; Drug Interactions; Embryo, Mammalian; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; GABA-A Receptor Antagonists; Gene Expression Regulation; Glucose Transporter Type 3; Green Fluorescent Proteins; Hexoses; Hippocampus; Humans; Intracellular Signaling Peptides and Proteins; Membrane Proteins; Neurons; Nitric Oxide; Nitric Oxide Synthase Type I; Potassium Channel Blockers; Protein Transport; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Serine; Synapses; Synaptosomes; Thionucleotides; Time Factors; Transfection; Valine | 2011 |
Multiple pathways from three types of sugar receptor sites to metabotropic transduction pathways of the blowfly: study by the whole cell-clamp experiments.
Topics: Adenylyl Cyclase Inhibitors; Aminoquinolines; Animals; Chemoreceptor Cells; Cyclic AMP; Cyclic GMP; Dideoxyadenosine; Diptera; Estrenes; Fructose; Guanylate Cyclase; Patch-Clamp Techniques; Pyrrolidinones; Signal Transduction; Sucrose; Taste; Type C Phospholipases; Valine | 2011 |
Thioglycine and L-thiovaline: biologically active H₂S-donors.
Topics: Amino Acids; Animals; Aorta; Cyclic GMP; Glycine; Hydrogen Sulfide; Mice; Myocytes, Smooth Muscle; Rats; Valine | 2012 |
Telmisartan activates endothelial nitric oxide synthase via Ser1177 phosphorylation in vascular endothelial cells.
Topics: AMP-Activated Protein Kinases; Animals; Antihypertensive Agents; Aorta; Benzimidazoles; Benzoates; Cyclic GMP; Enzyme Activation; Gene Expression Regulation; Human Umbilical Vein Endothelial Cells; Humans; Male; Mice; Mice, Inbred C57BL; Nitric Oxide Synthase Type III; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Signal Transduction; Telmisartan; Tetrazoles; Valine; Valsartan | 2014 |